Patents
Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
03/2015
03/03/2015US8969327 Substituted androst-4-ene diones
01/2015
01/27/2015US8940719 Lithocholic acid analogues that inhibit sialyltransferase
01/08/2015US20150011739 Tandem facial amphiphiles
01/01/2015US20150005518 Process for alkynylating 16-substituted-17-keto steroids
10/2014
10/30/2014US20140323748 Water-soluble ursodeoxycholic acid prodrugs
09/2014
09/23/2014US8841284 Compound having neurite-outgrowing activity
09/02/2014US8822441 Ecdysterone synthesis derivative, preparation method and use thereof
07/2014
07/08/2014US8771629 Nano-carbon material production apparatus and method
06/2014
06/25/2014CN101568547B 作为17βHSD抑制剂的被取代的雌三烯衍生物 As 17βHSD inhibitors substituted derivatives of estratrienes
06/19/2014WO2014091158A1 Testosterone derivatives with a carboxyalkyl substitution in position 3 and use thereof for the production of labelled steroids for determining the concentration of testosterone in a biological sample
06/04/2014EP2736918A1 Progesterone antagonists
06/04/2014CN103842370A Progesterone antagonists
05/2014
05/20/2014US8729257 Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof
04/2014
04/17/2014US20140107089 Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
04/15/2014CA2642566C 17-phosphorous steroid derivatives useful as progesterone receptor modulators
04/09/2014EP2714710A1 Process for the production of estetrol intermediates
04/02/2014CN103703014A Process for the production of estetrol intermediates
04/01/2014CA2669767C Progesterone receptor antagonists
02/2014
02/26/2014CN103601786A Preparation method of methylprednisolone key intermediate
02/19/2014CN103588848A Synthetic method for ginsenoside M1 and tri-methyl-chlorosilane full etherification reaction
12/2013
12/27/2013WO2013192097A1 Preparation, uses and solid forms of obeticholic acid
12/27/2013CA2877122A1 Preparation, uses and solid forms of obeticholic acid
12/11/2013CN103435676A Phytosterol phosphorylation amino-acid ester derivative and synthetic method thereof
11/2013
11/13/2013CN102516348B 16S-Methyl-20S-droxypregna compound, and synthesis method and uses thereof
10/2013
10/29/2013US8569276 Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
10/03/2013WO2013034780A3 Process for the preparation of estetrol and related compounds
08/2013
08/21/2013CN103254266A Steroid zinc metal complex and preparation method thereof as well as application of complex in preparation of antitumor medicines
07/2013
07/24/2013EP2616477A2 6-substituted demethyl-estradiol derivatives as er-beta agonists
07/03/2013CN103183715A Furostan saponin derivative and purpose thereof
06/2013
06/27/2013WO2013091120A1 Protected linker compounds
05/2013
05/22/2013EP2594577A1 Process for preparing guggulsterones and guggulsterol
04/2013
04/17/2013CN103044514A Preparation method of 3beta-hydroxy-6-thiosemicarbazone steroid metal complex and application of metal complex in antineoplastic drug
04/03/2013CN102234303B Novel ecdysterone synthetic derivative and preparation method and application thereof
03/2013
03/20/2013CN102311478B Composite lipid comprising cholesterol group and application thereof
03/13/2013EP2567966A1 Novel ecdysterone synthesis derivative, preparation method and use thereof
02/2013
02/28/2013US20130053586 Novel Ecdysterone Synthesis Derivative, Preparation Method and Use Thereof
02/28/2013US20130053507 Hydrophobic ceragenin compounds and devices incorporating same
02/28/2013US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use
02/13/2013EP2556083A2 Non-hormonal steroid modulators of nf- kappa b for treatment of disease
01/2013
01/31/2013WO2013016725A1 Progesterone antagonists
01/31/2013CA2846573A1 Progesterone antagonists
01/09/2013EP2543674A1 Method for producing silylenol ethers
12/2012
12/06/2012WO2012164096A1 Process for the production of estetrol intermediates
12/06/2012CA2835981A1 Process for the production of estetrol intermediates
11/2012
11/28/2012CN102796155A Nucleotide and oligonucleotide prodrugs
11/08/2012US20120283217 Modulators of amyloid-beta production
10/2012
10/30/2012CA2669355C Guggulphospholipid methods and compositions
10/03/2012CN101541823B Progesterone receptor antagonists
09/2012
09/25/2012US8273727 Lipid-analogous phosphoric triesters
09/19/2012CN101421290B 17-phosphorous steroid derivatives useful as progesterone receptor modulators
09/12/2012EP2497776A2 Process for the production of tibolone
09/05/2012CN101942006B Hydroxyl group/keto group synchronous derivatization method of endocrine disturbing chemicals in steroid environment
09/05/2012CN101622268B Industrial method for the synthesis of 17-acetoxy-11beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
09/04/2012CA2500768C Lipid-analog phosphoric acid triester
08/2012
08/23/2012US20120215006 Synthesis of phosphoric esters
08/02/2012US20120195988 Therapeutic Uses for Plants of the Capsicum Genus
06/2012
06/27/2012EP1989217B1 11-phosphorous steroid derivatives useful as progesterone receptor modulators
06/27/2012CN102516348A 16S-Methyl-20S-droxypregna compound, and synthesis method and uses thereof
06/13/2012EP2463292A1 Compound having neurite-outgrowing activity
05/2012
05/15/2012CA2517893C Use as medications of cholest-4-en-3-one derivatives, pharmaceutical compounds containing them, new derivatives and their preparation process
05/10/2012US20120116064 Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof
03/2012
03/22/2012US20120071570 Novel acyl acidic amino acid ester
03/14/2012EP2427472A1 Lipophilic polynucleotide conjugates
02/2012
02/07/2012CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders
01/2012
01/24/2012CA2163748C Methods and compositions for inducing sleep
01/11/2012CN102311478A Composite lipid comprising cholesterol group and intermediate, preparation method as well as application thereof
11/2011
11/10/2011WO2011137759A1 Novel ecdysterone synthesis derivative, preparation method and use thereof
11/09/2011CN102234303A Novel ecdysterone synthetic derivative and preparation method and application thereof
10/2011
10/12/2011EP2160398B1 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS
10/05/2011EP1706415B1 Lipid- derivatized bisphosphonic acid
10/05/2011CN101415720B 11-phosphorous steroid derivatives useful as progesterone receptor modulators
09/2011
09/14/2011EP2364085A1 Releasable cationic lipids for nucleic acids delivery systems
09/06/2011US8013147 Heterocyclic compounds and their use in the detection of nucleic acids
08/2011
08/23/2011US8003629 21-substituted progesterone derivatives as new antiprogestational agents
07/2011
07/21/2011US20110177156 Sterol-Modified Amphiphilic Lipids
07/07/2011WO2011081937A1 Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
07/07/2011US20110165603 Small molecule fluorescent sensors for detection of post-translationalmodifications and protein interactions in bioassays
04/2011
04/07/2011US20110082306 Birch reduction of steroid substrates via alkali metal - silica gel materials
03/2011
03/17/2011WO2010114305A3 Pegylated betulin derivative, and cosmetic composition containing the same
03/16/2011EP2294077A1 Corticosteroid linked beta-agonist compounds for use in therapy
03/09/2011EP2292588A1 Ceramide dimers and their use as medicine or cosmetic preparation
02/2011
02/24/2011US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds
02/16/2011EP2284176A1 Process for preparing guggulsterones and guggulsterol
02/15/2011CA2628883C Novel 3'-modified oligonucleotide derivatives
02/08/2011US7884222 Process for the production of tibolone
01/2011
01/12/2011CN101942006A Hydroxyl group/keto group synchronous derivatization method of steroid environment endocrine disturbing chemicals
01/05/2011EP2268655A2 Birch reduction of steroid substrates via alkali metal-silica gel materials
11/2010
11/24/2010CN101896498A Method for the aromatization of 19-nor-androst-4-en-3-ones into estra-1,3,5(10)-trienes
11/18/2010WO2010132743A1 Corticosteroid beta-agonist compounds for use in therapy
11/16/2010CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
11/03/2010EP2246359A1 Process for obtaining fluorometholone and intermediates therefor
10/2010
10/28/2010WO2010122096A1 Process for obtaining fluorometholone and intermediates therefor
10/20/2010EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
10/07/2010WO2010114305A2 Pegylated betulin derivative, and cosmetic composition containing the same
09/2010
09/29/2010EP2231692A1 Method for the aromatization of 19-nor-androst-4-en-3-ones into estra-1,3,5(10)-trienes
09/23/2010US20100240916 Process for obtaining steroidal phosphate compounds
08/2010
08/25/2010EP2219587A1 Sterol-modified amphiphilic lipids
08/12/2010US20100204497 Process For The Preparation of 7 alpha-Methylsteroids
07/2010
07/22/2010US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use
07/20/2010US7759330 21-substituted progesterone derivatives as new antiprogestational agents
1 2 3 4 5 6 7 8 9 10 11 ... 16